180 related articles for article (PubMed ID: 27932787)
1. High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.
Tasian SK; Hurtz C; Wertheim GB; Bailey NG; Lim MS; Harvey RC; Chen IM; Willman CL; Astles R; Zebrowski A; Reshmi SC; Li MM; Frey NV; Luger SM; Carroll M; Perl AE
Leukemia; 2017 Apr; 31(4):981-984. PubMed ID: 27932787
[No Abstract] [Full Text] [Related]
2. Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.
Ribera JM; García O; Fernández-Abellán P; Lavilla E; Bernal MT; González-Campos J; Brunet S; Monteserín MC; Montesinos P; Sarrá J; Calbacho M; Alvarez-Larrán A; Tormo M; Oriol A;
Br J Haematol; 2012 Nov; 159(4):485-8. PubMed ID: 22966847
[No Abstract] [Full Text] [Related]
3. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance.
Ottmann O
Lancet Haematol; 2018 Dec; 5(12):e606-e607. PubMed ID: 30501865
[No Abstract] [Full Text] [Related]
5. Ponatinib for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Narayanan V; Pollyea DA; Gutman JA; Jimeno A
Drugs Today (Barc); 2013 Apr; 49(4):261-9. PubMed ID: 23616953
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ottmann OG; Wassmann B
Hematology Am Soc Hematol Educ Program; 2005; ():118-22. PubMed ID: 16304368
[TBL] [Abstract][Full Text] [Related]
7. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
Short NJ; Kantarjian HM; Sasaki K; Ravandi F; Ko H; Cameron Yin C; Garcia-Manero G; Cortes JE; Garris R; O'Brien SM; Patel K; Khouri M; Thomas D; Jain N; Kadia TM; Daver NG; Benton CB; Issa GC; Konopleva M; Jabbour E
Am J Hematol; 2017 Mar; 92(3):238-243. PubMed ID: 28006851
[TBL] [Abstract][Full Text] [Related]
8. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Fielding AK
Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039
[TBL] [Abstract][Full Text] [Related]
9. Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide.
Vitale A; Grammatico S; Capria S; Fiocchi C; Foà R; Meloni G
Haematologica; 2009 Oct; 94(10):1471-3. PubMed ID: 19608688
[No Abstract] [Full Text] [Related]
10. Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia.
Ottmann OG; Larson RA; Kantarjian HM; le Coutre PD; Baccarani M; Hochhaus A; Kim DW; Fan X; Novick S; Giles FJ
Leukemia; 2013 Jun; 27(6):1411-3. PubMed ID: 23138184
[No Abstract] [Full Text] [Related]
11. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
[TBL] [Abstract][Full Text] [Related]
12. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.
Mustafa Ali MK; Sabha MM; Al-Rabi KH
Platelets; 2015; 26(5):491-4. PubMed ID: 25025538
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and outcomes of unrelated bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) pre-treated with tyrosine kinase inhibitors.
Yoshimura T; Nakane T; Hirose A; Koh H; Nakamae M; Aimoto M; Nishimoto M; Hayashi Y; Terada Y; Nakamae H; Hino M
Osaka City Med J; 2013 Jun; 59(1):9-21. PubMed ID: 23909077
[TBL] [Abstract][Full Text] [Related]
15. Ponatinib: A new tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shamroe CL; Comeau JM
Ann Pharmacother; 2013 Nov; 47(11):1540-6. PubMed ID: 24265264
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.
Forghieri F; Luppi M; Potenza L
Hematology; 2015 Dec; 20(10):618-9. PubMed ID: 26574786
[No Abstract] [Full Text] [Related]
17. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
[TBL] [Abstract][Full Text] [Related]
18. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
[TBL] [Abstract][Full Text] [Related]
19. Advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Stock W
Clin Adv Hematol Oncol; 2008 Jul; 6(7):487-8. PubMed ID: 18654114
[No Abstract] [Full Text] [Related]
20. [New therapeutic strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Usui N
Rinsho Ketsueki; 2006 Apr; 47(4):294-302. PubMed ID: 16715964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
